Skip to main content

Advertisement

Log in

Posaconazole and risk of cutaneous squamous cell carcinoma after lung transplantation: a single institution, retrospective cohort study

  • ORIGINAL PAPER
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

Data will be made available upon request.

References

  1. Neoh CF, Snell FI, Levvey B, Kotsimbos T, Morrissey CO, Slavin MA et al (2013) Preemptive treatment with voriconazole in lung transplant recipients. Transpl Infect Dis 15(4):344–353

    Article  CAS  PubMed  Google Scholar 

  2. Jacobsen AA, Papo YB, Sarro R, Weisse K, Strasswimmer J (2016) Posaconazole substitution for voriconazole-associated phototoxic effects. JAMA Dermatol 152(7):839–841

    Article  PubMed  Google Scholar 

  3. Kolaitis NA, Duffy E, Zhang A, Lo M, Barba DT, Chen M et al (2017) Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation. Transpl Int 30(1):418

    Article  Google Scholar 

  4. Kuklinski LF, Li S, Karagas MR, Weng WK, Kwong BY (2017) Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation. J Am Acad Dermatol 77(4):706–713

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Tang H, Shi W, Song Y, Han J (2019) Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: a systematic review and meta analysis. J Am Acad Dermatol 80(2):500–507

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The research described was supported by NIH/National Center for Advancing Translation Science (NCATS) UCLA CTSI Grant NUMBER UL1TR001881

Author information

Authors and Affiliations

Authors

Contributions

LFK designed the study, collected data, and wrote the manuscript AMK analyzed data and wrote the manuscript AS collected data and reviewed the manuscript NA reviewed the manuscript TTS designed the study and reviewed the manuscript RS designed the study and reviewed the manuscript SSW designed the study and reviewed the manuscript

Corresponding author

Correspondence to Lawrence F. Kuklinski.

Ethics declarations

Conflict of interest

The author declares that have no conflict of interest.

Ethical approval

Approved by UCLA IRB, #11–003042.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuklinski, L.F., Klomhaus, A.M., Shen, A. et al. Posaconazole and risk of cutaneous squamous cell carcinoma after lung transplantation: a single institution, retrospective cohort study. Arch Dermatol Res 315, 2643–2646 (2023). https://doi.org/10.1007/s00403-023-02699-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-023-02699-y

Keywords

Navigation